Organisation › Details

VantAI (US)

https://www.vant.ai

VantAI is at the forefront of applying generative AI technologies to drug discovery. With a cross-disciplinary team of scientists and engineers, VantAI is well suited to power solutions for induced proximity, where the nuance of protein-protein interactions, such as those in protein degradation, has outsized influence on drug success. *

	Start	2019-01-01 established
	Group	Roivant (Group)
	Industry	AI-based drug discovery / AI-based drug development
	Industry 2	artificial intelligence (AI) / machine learning (ML)
	Person	Carpenter, Zachary (Zach) (Roivant 202402 CEO + Co-Founder of VantAI)
	Person 2	Kim, Jae Won (Roivant 202402– COO + CFO of VantAI before Orum Therapeutics + Citigroup Healthcare Investment Banking)

	Region	New York, NY
	Country	United States (USA)
	City	10003 New York, NY
		Address record changed: 2024-02-14

Basic data	Employees	n. a.

		* Document for »About Section«: VantAI. (2/13/24). "Press Release: VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence". New York, NY.

		Record changed: 2024-02-25

More documents for Roivant (Group)

[1] Organon & Co.. (9/18/24). "Press Release: Organon to Acquire Dermavant including Its Innovative Dermatologic Therapy, Vtama (tapinarof) Cream, 1%". Jersey City, NJ....
[2] Roivant Sciences GmbH. (9/10/24). "Press Release: Roivant Unveils New Pipeline Program Mosliciguat, a Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator". Basel, London & New York, NY....
[3] VantAI. (2/13/24). "Press Release: VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence". New York, NY....
[4] VantAI. (2/7/24). "Press Release: VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer". New York, NY....
[5] Roche. (10/23/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire Telavant". Basel....
[6] VantAI. (4/20/22). "Press Release: VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders". new York, NY & Ingelheim....
[7] Affimed N.V.. (3/31/22). "Press Release: Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress". Heidelberg....
[8] Roivant Sciences GmbH. (2/26/21). "Press Release: Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics". New York, NY, Boston, MA & Basel....
[9] Medigene AG. (11/12/20). "Press Release: Medigene Provides Q3 2020 Update". Planegg-Martinsried....
[10] Medigene AG. (10/19/20). "Press Release: Medigene and Cytovant Enter into Service Agreement for DC Vaccine Manufacturing Process Development". Planegg-Martinsried....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]